Talphera (TLPH) Preferred Stock Liabilities (2010 - 2022)
Talphera (TLPH) posted quarterly Preferred Stock Liabilities of $315000.0 for Q3 2022, down 99.44% quarter-over-quarter from $55.9 million in Q4 2010.
Talphera (TLPH) Preferred Stock Liabilities (2010 - 2022) Analysis & Trends
Talphera's Preferred Stock Liabilities history runs 2 years deep, the most recent figure standing at $315000.0 for Q3 2022.
- In Q3 2022, Preferred Stock Liabilities changed N/A year-over-year to $315000.0; the TTM figure through Sep 2022 stood at $315000.0 (changed N/A YoY), while the FY2010 annual figure was $55.9 million, changed N/A from the prior year.
- Preferred Stock Liabilities for Q3 2022 stood at $315000.0, down from $55.9 million in the prior quarter.
- The five-year high for Preferred Stock Liabilities was $315000.0 in Q3 2022, with the low at $315000.0 in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Talphera | 89.88 Mn | 89.88 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 315,000.00 |
| Dec 31, 2010 | 55.94 Mn |